<SEC-DOCUMENT>0001193125-25-004065.txt : 20250110
<SEC-HEADER>0001193125-25-004065.hdr.sgml : 20250110
<ACCEPTANCE-DATETIME>20250110070139
ACCESSION NUMBER:		0001193125-25-004065
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20250109
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250110
DATE AS OF CHANGE:		20250110

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Repare Therapeutics Inc.
		CENTRAL INDEX KEY:			0001808158
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			Z4
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39335
		FILM NUMBER:		25520347

	BUSINESS ADDRESS:	
		STREET 1:		7171 FREDERICK BANTING
		STREET 2:		SUITE 270, BUILDING 2
		CITY:			SAINT-LAURENT
		STATE:			A8
		ZIP:			H4S 1Z9
		BUSINESS PHONE:		(857) 412-7018

	MAIL ADDRESS:	
		STREET 1:		7171 FREDERICK BANTING
		STREET 2:		SUITE 270, BUILDING 2
		CITY:			SAINT-LAURENT
		STATE:			A8
		ZIP:			H4S 1Z9
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d904622d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:rptx="http://www.reparerx.com/20250109" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-types="http://fasb.org/us-types/2024" xmlns:srt-types="http://fasb.org/srt-types/2024" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric id="Hidden_dei_EntityTaxIdentificationNumber" name="dei:EntityTaxIdentificationNumber" contextRef="duration_2025-01-09_to_2025-01-09">00-0000000</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_AmendmentFlag_duration_2025-01-09_to_2025-01-09" name="dei:AmendmentFlag" contextRef="duration_2025-01-09_to_2025-01-09">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey_duration_2025-01-09_to_2025-01-09" name="dei:EntityCentralIndexKey" contextRef="duration_2025-01-09_to_2025-01-09">0001808158</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xlink:type="simple" xlink:href="rptx-20250109.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase"/> </ix:references> <ix:resources> <xbrli:context id="duration_2025-01-09_to_2025-01-09"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001808158</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-09</xbrli:startDate> <xbrli:endDate>2025-01-09</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p><p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p><p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p><p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p><p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Washington, D.C. 20549</p><p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"><p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div><p style="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <span style="white-space:nowrap"><ix:nonNumeric name="dei:DocumentType" contextRef="duration_2025-01-09_to_2025-01-09" id="Fact_1">8-K</ix:nonNumeric></span></p><p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"><p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div><p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p><p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section&#160;13 or 15(d)</p><p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of the Securities Exchange Act of 1934</p><p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2025-01-09_to_2025-01-09" format="ixt:date-monthname-day-year-en" id="Fact_0">January&#160;9, 2025</ix:nonNumeric></p><p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"><p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div><p style="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric contextRef="duration_2025-01-09_to_2025-01-09" name="dei:EntityRegistrantName" id="ixv-282">Repare Therapeutics Inc.</ix:nonNumeric></p><p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact Name of Registrant as Specified in Its Charter)</p><p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"><p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div><p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric contextRef="duration_2025-01-09_to_2025-01-09" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:edgarprovcountryen" id="ixv-283">Qu&#233;bec</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric contextRef="duration_2025-01-09_to_2025-01-09" name="dei:EntityFileNumber" id="ixv-284">001-39335</ix:nonNumeric></span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style=" -sec-ix-hidden:Hidden_dei_EntityTaxIdentificationNumber" id="Fact_2">Not applicable</span></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(State or Other Jurisdiction</p><p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">of Incorporation)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Commission</p><p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">File Number)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(I.R.S. Employer</p><p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Identification No.)</p></td></tr> </table><p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:50%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:48%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:bottom"><p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric contextRef="duration_2025-01-09_to_2025-01-09" name="dei:EntityAddressAddressLine1" id="ixv-285">7171 Frederick-Banting, Building 2</ix:nonNumeric></p><p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric contextRef="duration_2025-01-09_to_2025-01-09" name="dei:EntityAddressAddressLine2" id="ixv-286">Suite 270</ix:nonNumeric></p><p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><span style="white-space:nowrap"><ix:nonNumeric contextRef="duration_2025-01-09_to_2025-01-09" name="dei:EntityAddressCityOrTown" id="ixv-287">St-Laurent</ix:nonNumeric>,</span> <ix:nonNumeric contextRef="duration_2025-01-09_to_2025-01-09" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="ixv-288">Qu&#233;bec</ix:nonNumeric>, <ix:nonNumeric contextRef="duration_2025-01-09_to_2025-01-09" name="dei:EntityAddressCountry" format="ixt-sec:countrynameen" id="ixv-289">Canada</ix:nonNumeric></p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:bottom"><span style="font-weight:bold"><ix:nonNumeric contextRef="duration_2025-01-09_to_2025-01-09" name="dei:EntityAddressPostalZipCode" id="ixv-290">H4S&#160;1Z9</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Address of Principal Executive Offices)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Zip Code)</span></td></tr> </table><p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Registrant&#8217;s Telephone Number, Including Area Code: (<ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2025-01-09_to_2025-01-09" id="Fact_3">857</ix:nonNumeric>) <span style="white-space:nowrap"><ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2025-01-09_to_2025-01-09" id="Fact_4">412-7018</ix:nonNumeric></span></p><p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Not Applicable</p><p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Former Name or Former Address, if Changed Since Last Report.)</p><p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"><p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div><p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p><p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric contextRef="duration_2025-01-09_to_2025-01-09" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox" id="ixv-293">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr> </table><p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric contextRef="duration_2025-01-09_to_2025-01-09" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox" id="ixv-294">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12)</span></p></td></tr> </table><p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric contextRef="duration_2025-01-09_to_2025-01-09" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox" id="ixv-295">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b))</span></p></td></tr> </table><p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric contextRef="duration_2025-01-09_to_2025-01-09" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox" id="ixv-296">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c))</span></p></td></tr> </table><p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section&#160;12(b) of the Act:</p><p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"><p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"><p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading<br/>Symbol</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"><p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange</p><p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric contextRef="duration_2025-01-09_to_2025-01-09" name="dei:Security12bTitle" id="ixv-297">Common shares, no par value</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric contextRef="duration_2025-01-09_to_2025-01-09" name="dei:TradingSymbol" id="ixv-298">RPTX</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric contextRef="duration_2025-01-09_to_2025-01-09" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="ixv-299">The Nasdaq Stock Market LLC</ix:nonNumeric></td></tr> </table><p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934 <span style="white-space:nowrap">(&#167;240.12b-2</span> of this chapter).</p><p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emerging growth company <ix:nonNumeric contextRef="duration_2025-01-09_to_2025-01-09" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="ixv-300">&#9744;</ix:nonNumeric></p><p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act. &#9744;</p><p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p><p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p><p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div><p style="page-break-before:always"></p> <hr style="color:#999999;height:3px;width:100%;clear:both"/> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top"><span style="font-weight:bold">Item&#8201;2.02.</span></td>
<td style="vertical-align:top"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Results of Operations and Financial Condition.</p></td></tr> </table><p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On January&#160;9, 2025, Repare Therapeutics Inc. (the &#8220;Company&#8221;) announced that its preliminary unaudited cash, cash equivalents and marketable securities as of December&#160;31, 2024 was approximately $153&#160;million.</p><p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#8217;s audited consolidated financial statements at and for the year ended December&#160;31, 2024 are not yet available. As a result, the financial information described in this Item 2.02 is preliminary and unaudited, and represents management&#8217;s estimate as of the date of this Current Report on Form <span style="white-space:nowrap">8-K,</span> and is subject to completion of the Company&#8217;s financial closing procedures for the fourth quarter and fiscal year ended December&#160;31, 2024. These preliminary results may materially differ from the actual results that will be reflected in the Company&#8217;s audited consolidated financial statements when they are completed and publicly disclosed. The Company&#8217;s independent registered public accounting firm has not conducted an audit or review of, and does not express an opinion or any other form of assurance with respect to, the Company&#8217;s preliminary results.</p><p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The financial information presented in this Item 2.02 does not present all necessary information for a complete understanding of the Company&#8217;s financial condition as of December&#160;31, 2024, or the Company&#8217;s results of operations for the year ended December&#160;31, 2024. This preliminary financial data should not be viewed as a substitute for full financial statements for the year ended December&#160;31, 2024 prepared in accordance with U.S. GAAP.</p><p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The information contained in Item 2.02 of this Current Report on Form <span style="white-space:nowrap">8-K</span> shall not be deemed &#8220;filed&#8221; for purposes of Section&#160;18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that section, and shall not be deemed incorporated by reference into any of the Company&#8217;s filings under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), or the Exchange Act, whether made before or after the date hereof, regardless of any general incorporation language in such filing, except as shall be expressly set forth by specific reference in such filing.</p><p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top"><span style="font-weight:bold">Item&#8201;7.01</span></td>
<td style="vertical-align:top"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Regulation FD Disclosure.</p></td></tr> </table><p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On January&#160;9, 2025, the Company issued a press release announcing a <span style="white-space:nowrap">re-alignment</span> of resources and a <span style="white-space:nowrap">re-prioritization</span> of its clinical portfolio to focus on the continued advancement of its Phase 1 clinical programs, <span style="white-space:nowrap">RP-1664</span> and <span style="white-space:nowrap">RP-3467,</span> along with an update to its cash position and runway guidance. The Company expects that the consequent savings of its proposed plan to await late-stage clinical funding combined with planned future cost and headcount reductions will extend the Company&#8217;s cash runway into <span style="white-space:nowrap">mid-2027.</span> A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form <span style="white-space:nowrap">8-K</span> and is incorporated herein by reference.</p><p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The information contained in Item 7.01 of this Current Report on Form <span style="white-space:nowrap">8-K,</span> including Exhibit 99.1 attached hereto, shall not be deemed &#8220;filed&#8221; for purposes of Section&#160;18 of the Exchange Act or otherwise subject to the liabilities of that section, and shall not be deemed incorporated by reference into any of the Company&#8217;s filings under the Securities Act or the Exchange Act, whether made before or after the date hereof, regardless of any general incorporation language in such filing, except as shall be expressly set forth by specific reference in such filing.</p><p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Cautionary Note Regarding Forward-Looking Statements</p><p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This Current Report on Form 8-K contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, and the securities laws of Canada. All statements in this Current Report on Form 8-K other than statements of historical fact could be deemed forward looking including, but not limited to, statements regarding the Company&#8217;s current business plans and objectives; the expected cost-savings from the proposed streamlined operations which include future cost and headcount reductions; and the estimated extended cash runway post-cost reductions. Words such as &#8220;plans,&#8221; &#8220;expects,&#8221; &#8220;will,&#8221; &#8220;shall,&#8221; &#8220;anticipates,&#8221; &#8220;continue,&#8221; &#8220;expand,&#8221; &#8220;advance,&#8221; &#8220;believes,&#8221; &#8220;guidance,&#8221; &#8220;target,&#8221; &#8220;may,&#8221; &#8220;remain,&#8221; &#8220;project,&#8221; &#8220;outlook,&#8221; &#8220;intend,&#8221; &#8220;estimate,&#8221; &#8220;could,&#8221; &#8220;should,&#8221; and other words and terms of similar meaning and expression are intended to identify forward-looking statements, although not all forward-looking statements contain such terms. Forward-looking statements are based on management&#8217;s current beliefs and assumptions that are subject to risks and uncertainties and are not guarantees of future performance. Actual results could differ materially from those contained in any forward-looking statement as a result of various factors, including, without limitation: the Company&#8217;s ability to successfully implement the proposed cost-cutting measures; the impact of the cost-reduction measures on the Company&#8217;s business; the effect of the announcement of a future headcount reduction on the ability of the Company to retain and hire key personnel; risks associated with the disruption of management&#8217;s attention from ongoing business operations due to the resource re-alignment and clinical portfolio reprioritization; and the risk of litigation and/or regulatory actions related to the proposed resource re-alignment. Given these risks and uncertainties, you are cautioned not to place undue reliance on such forward-looking statements. For a discussion of other risks and uncertainties, and other important factors, any of which could cause the Company&#8217;s actual results to differ from those contained in the forward-looking statements, see the section titled &#8220;Risk Factors&#8221; in the Company&#8217;s Quarterly Report on Form 10-Q filed with the SEC and the Qu&#233;bec Autorit&#233; des March&#233;s Financiers on November 7, 2024, as updated by the Company&#8217;s subsequent filings with the Securities and Exchange Commission. All information in this Current Report on Form 8-K is as of the date of the release, and the Company undertakes no duty to update this information or to publicly announce the results of any revisions to any of such statements to reflect future events or developments, except as required by law.</p></div></div><p style="page-break-before:always"></p> <hr style="color:#999999;height:3px;width:100%;clear:both"/> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top"><span style="font-weight:bold">Item&#8201;9.01</span></td>
<td style="vertical-align:top"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits.</p></td></tr></table><p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d) Exhibits</p><p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td/>
<td style="vertical-align:bottom;width:4%"/>
<td style="width:93%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:bottom;white-space:nowrap"><p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Exhibit</p><p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">No.</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"><p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; font-size:8pt; font-family:Times New Roman;font-weight:bold">Description</p></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">99.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d904622dex991.htm">Press Release dated January&#160;9, 2025 </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (embedded within the Inline XBRL document)</td></tr></table><p style="font-size:18pt; margin-top:0pt; margin-bottom:0pt">&#160;</p></div></div><p style="page-break-before:always"></p> <hr style="color:#999999;height:3px;width:100%;clear:both"/> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURES</p><p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p><p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:40%;border:0;margin-left:auto">
<tr>
<td style="width:7%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:92%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top" colspan="3"><span style="font-weight:bold">REPARE THERAPEUTICS INC.</span></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Lloyd M. Segal</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Lloyd M. Segal</p><p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">President and Chief Executive Officer</p></td></tr></table></div><p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dated January&#160;10, 2025</p></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d904622dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g904622g0110045741416.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Repare Therapeutics Announces Portfolio <FONT STYLE="white-space:nowrap">Re-Prioritization,</FONT>
Partnering Initiatives and Cost Reductions </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>Realigning resources to extend runway to <FONT STYLE="white-space:nowrap">mid-2027</FONT>
</I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>Focus on clinical development of <FONT STYLE="white-space:nowrap">RP-1664</FONT> (PLK4 inhibitor) and
<FONT STYLE="white-space:nowrap">RP-3467</FONT> (Pol</I><FONT STYLE="FONT-FAMILY:SYMBOL">&#113;</FONT><I></I><I> ATPase inhibitor), with initial clinical readouts expected beginning in Q3 2025 </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>Exploring partnerships for continued development of Lunre+Camo and other assets </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>CAMBRIDGE, Mass. &amp; MONTREAL&#151;(BUSINESS WIRE)&#151;Jan. 9, 2025&#151;</B>Repare Therapeutics Inc. (&#147;Repare&#148; or the &#147;Company&#148;)
(Nasdaq: RPTX), a leading clinical-stage precision oncology company, today announced a <FONT STYLE="white-space:nowrap">re-alignment</FONT> of resources and a <FONT STYLE="white-space:nowrap">re-prioritization</FONT> of its clinical portfolio to
focus on the continued advancement of its Phase 1 clinical programs, <FONT STYLE="white-space:nowrap">RP-1664</FONT> (PLK4 inhibitor) and <FONT STYLE="white-space:nowrap">RP-3467</FONT> (Pol<FONT STYLE="FONT-FAMILY:SYMBOL">&#113;</FONT> ATPase
inhibitor). Repare also announced its intention to seek partnering opportunities across its portfolio, including for lunresertib and camonsertib (&#147;Lunre+Camo&#148;) prior to any start of pivotal development. The consequent savings of late-stage
clinical funding combined with planned cost and headcount reductions are expected to extend Repare&#146;s cash runway into <FONT STYLE="white-space:nowrap">mid-2027.</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;While Lunre+Camo demonstrated positive results from our Phase 1 clinical trial, after careful consideration we have decided to progress this program
into pivotal trials contingent on securing a strategic partner to fund further development. We are focused on achieving near-term inflection points for our Phase 1 clinical assets, <FONT STYLE="white-space:nowrap">RP-1664</FONT> and <FONT
STYLE="white-space:nowrap">RP-3467,</FONT> both of which have the potential to address significant unmet patient needs and deliver important catalysts in 2025,&#148; said Lloyd M. Segal, President and Chief Executive Officer of Repare.
&#147;Combined with other initiatives, these changes, which we will implement later this quarter, provide the foundation for meaningful value creation.&#148; </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Recent Pipeline Progress&nbsp;&amp; Upcoming Milestones of Prioritized Clinical Programs: </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">RP-1664:</FONT> <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">First-in-class,</FONT></FONT> highly
selective, oral inhibitor of PLK4 </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Repare is evaluating <FONT STYLE="white-space:nowrap">RP-1664</FONT> as a monotherapy in the Phase 1 LIONS clinical
trial in adult and adolescent patients with TRIM37-high solid tumors. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Upcoming Expected Milestones: </I></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Q3 2025: Initiation of a Phase 1/2 expansion trial in pediatric neuroblastoma </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Q4 2025: Initial topline safety, tolerability and early efficacy data from the LIONS trial </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><FONT STYLE="white-space:nowrap">Mid-2026:</FONT> Trial completion, final trial readout for <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">proof-of-concept</FONT></FONT> from the LIONS trial </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT
STYLE="white-space:nowrap">RP-3467:</FONT> Potential <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">best-in-class</FONT></FONT> Pol</B><FONT STYLE="FONT-FAMILY:SYMBOL">&#113;</FONT><B></B><B> ATPase inhibitor </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Repare is dosing patients in the Phase 1 POLAR clinical trial evaluating <FONT STYLE="white-space:nowrap">RP-3467</FONT> alone and in combination with the <FONT
STYLE="white-space:nowrap">poly-ADP</FONT> ribose polymerase (PARP) inhibitor, olaparib. This trial is enrolling patients with locally advanced or metastatic epithelial ovarian cancer, metastatic breast cancer, metastatic castration-resistant
prostate cancer, or pancreatic adenocarcinoma. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g904622g0110045741416.jpg" ALT="LOGO">
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Upcoming Expected Milestones: </I></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Q3 2025: Topline safety, tolerability and early efficacy data from the POLAR trial in monotherapy and in
combination with olaparib. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Lunresertib and Camonsertib </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Repare recently reported positive efficacy and safety data from the Phase 1 MYTHIC gynecologic expansion clinical trial evaluating the combination of
lunresertib and camonsertib (Lunre+Camo) at the recommended Phase 2 dose (RP2D) in patients with endometrial cancer (EC) and platinum-resistant ovarian cancer (PROC). Nearly half of patients with gynecologic cancers maintained progression-free
survival (PFS) at 24 weeks, comparing favorably to PFS for current standard of care. Repare intends to seek partnering opportunities for this program as a condition to advancing the program into planned and regulatory-supported pivotal development.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Repare is currently evaluating lunresertib in combination with Debio 0123, a highly selective, brain-penetrant, clinical WEE1 inhibitor, in patients with
advanced solid tumors harboring <I>CCNE1</I> amplification or <I>FBXW7</I> or <I>PPP2R1A</I> deleterious alterations as part of an ongoing 50/50 cost sharing collaboration with Debiopharm. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company will not continue to develop lunresertib or camonsertib in other studies, including the ongoing camonsertib
<FONT STYLE="white-space:nowrap">non-small</FONT> cell lung cancer expansion study, absent securing a partnership with a development partner. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Upcoming
Expected Milestone: </I></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Q2 2025: Enrollment completion of MYTHIC trial evaluating lunresertib in combination with Debio 0123 (WEE1
inhibitor) </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Cash Position and Financial Guidance: </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Repare ended 2024 with approximately $153&nbsp;million in cash, cash equivalents and marketable securities, which is anticipated with the implementation of the
cost-saving measures announced above to fund the Company&#146;s streamlined operations into <FONT STYLE="white-space:nowrap">mid-2027.</FONT> </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About&nbsp;Repare Therapeutics Inc. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Repare Therapeutics
is a leading clinical-stage precision oncology company enabled by its proprietary synthetic lethality approach to the discovery and development of novel therapeutics. The Company utilizes its genome-wide, CRISPR-enabled SNIPRx<SUP
STYLE="font-size:75%; vertical-align:top">&reg;</SUP> platform to systematically discover and develop highly targeted cancer therapies focused on genomic instability, including DNA damage repair. The Company&#146;s clinical-stage pipeline includes <FONT
STYLE="white-space:nowrap">RP-1664,</FONT> a Phase 1 PLK4 inhibitor; <FONT STYLE="white-space:nowrap">RP-3467,</FONT> a Phase 1 Pol<FONT STYLE="FONT-FAMILY:SYMBOL">&#113;</FONT> ATPase inhibitor; and lunresertib, a PKMYT1 inhibitor, and camonsertib,
a potential leading ATR inhibitor. For more information, please visit <U>reparerx.com</U> and follow @Reparerx on X (formerly Twitter) and LinkedIn. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g904622g0110045741416.jpg" ALT="LOGO">
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward-Looking Statements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This press release contains &#147;forward-looking statements&#148; within the meaning of the Private Securities Litigation Reform Act of 1995 and securities
laws in Canada. All statements in this press release other than statements of historical facts are &#147;forward-looking statements. These statements may be identified by words such as &#147;aims,&#148; &#147;anticipates,&#148; &#147;believes,&#148;
&#147;could,&#148; &#147;estimates,&#148; &#147;expects,&#148; &#147;forecasts,&#148; &#147;goal,&#148; &#147;intends,&#148; &#147;may,&#148; &#147;plans,&#148; &#147;possible,&#148; &#147;potential,&#148; &#147;seeks,&#148; &#147;will&#148; and
variations of these words or similar expressions that are intended to identify forward-looking statements, although not all forward-looking statements contain these words. Forward-looking statements in this press release include, but are not limited
to, statements regarding: the Company&#146;s plans for <FONT STYLE="white-space:nowrap">re-prioritization</FONT> of its portfolio and the implementation of other cost saving measures, and the expected impact of such actions; the Company&#146;s
preliminary unaudited balance of cash, cash equivalents and marketable securities as of the end of 2024 and the Company&#146;s anticipated cash runway; the Company&#146;s plans to secure a partner to fund further clinical development of camonsertib
and lunresertib; the potential, tolerability, efficacy and clinical progress of the Company&#146;s product candidates; and the design, objectives, initiation, timing, progress and results of current and future preclinical studies and clinical trials
of the Company&#146;s product candidates. These forward-looking statements are based on the Company&#146;s expectations and assumptions as of the date of this press release. Each of these forward-looking statements involves risks and uncertainties
that could cause the Company&#146;s clinical development programs, future results or performance to differ materially from those expressed or implied by the forward-looking statements. Many factors may cause differences between current expectations
and actual results, including: the potential that success in preclinical testing and earlier clinical trials does not ensure that later clinical trials will generate the same results or otherwise provide adequate data to demonstrate the efficacy and
safety of a product candidate; the impacts of macroeconomic conditions, including the conflict in Ukraine and the conflict in the Middle East, fluctuations in inflation and uncertain credit and financial markets, on the Company&#146;s business,
clinical trials and financial position; unexpected safety or efficacy data observed during preclinical studies or clinical trials; clinical trial site activation or enrollment rates that are lower than expected; the Company&#146;s ability to realize
the benefits of its collaboration and license agreements; changes in expected or existing competition; changes in the regulatory environment; the uncertainties and timing of the regulatory approval process; and unexpected litigation or other
disputes. Other factors that may cause the Company&#146;s actual results to differ from those expressed or implied in the forward-looking statements in this press release are identified in the section titled &#147;Risk Factors&#148; in the
Company&#146;s Quarterly Report on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> for the quarter ended September&nbsp;30, 2024 filed with the Securities and Exchange Commission (&#147;SEC&#148;) and the Qu&eacute;bec Autorit&eacute; des
March&eacute;s Financiers (&#147;AMF&#148;) on November&nbsp;7, 2024. The Company expressly disclaims any obligation to update any forward-looking statements contained herein, whether as a result of any new information, future events, changed
circumstances or otherwise, except as otherwise required by law. For more information, please visit reparerx.com and follow Repare on X (formerly Twitter) at @RepareRx and on LinkedIn at <U>https://www.linkedin.com/company/repare-therapeutics/</U>.
</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g904622g0110045741416.jpg" ALT="LOGO" STYLE="width:1.32083in;height:0.720833in;">
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Preliminary Financial Information </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Repare&#146;s audited consolidated financial statements at and for the year ended December&nbsp;31, 2024 are not yet available. As a result, the financial
information described in this press release is preliminary and unaudited, represents management&#146;s estimate as of the date hereof and is subject to completion of Repare&#146;s financial closing procedures for the fourth quarter and fiscal year
ended December&nbsp;31, 2024. This preliminary financial information may materially differ from the actual results that will be reflected in Repare&#146;s audited consolidated financial statements when such financial statements are completed and
publicly disclosed.&nbsp;Repare&#146;s independent registered public accounting firm has not conducted an audit or review of, and does not express an opinion or any other form of assurance with respect to, Repare&#146;s preliminary results. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Investor Relations&nbsp;&amp; Media Contact: </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Robin
Garner </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Vice President and Head of Investor Relations </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Repare
Therapeutics Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>investor@reparerx.com </U></P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>rptx-20250109.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - Donnelley Financial Solutions, Inc. -->
<!-- CTU Version: 74.0.3 -->
<!-- Creation date: 1/9/2025 7:12:50 PM Eastern Time -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:rptx="http://www.reparerx.com/20250109"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:us-types="http://fasb.org/us-types/2024"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://www.reparerx.com/20250109"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
    <xsd:import schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" namespace="http://www.xbrl.org/dtr/type/2022-03-31" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" namespace="http://xbrl.sec.gov/dei/2024" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="rptx-20250109_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="rptx-20250109_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.reparerx.com//20250109/taxonomy/role/DocumentDocumentAndEntityInformation" id="DocumentDocumentAndEntityInformation">
        <link:definition>000001 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>rptx-20250109_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - Donnelley Financial Solutions, Inc. -->
<!-- CTU Version: 74.0.3 -->
<!-- Creation date: 1/9/2025 7:12:50 PM Eastern Time -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address Address Line 1</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address Address Line 1</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address Address Line 2</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address Address Line 2</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address City Or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address City Or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address State Or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address State Or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:type="locator" xlink:label="dei_EntityAddressCountry" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCountry_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address Country</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCountry_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address Country</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>rptx-20250109_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - Donnelley Financial Solutions, Inc. -->
<!-- CTU Version: 74.0.3 -->
<!-- Creation date: 1/9/2025 7:12:49 PM Eastern Time -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.reparerx.com//20250109/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="rptx-20250109.xsd#DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.reparerx.com//20250109/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="20.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="21.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="24.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="25.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine2" order="26.011" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="26.031" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="26.131" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:type="locator" xlink:label="dei_EntityAddressCountry" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCountry" order="26.231" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="26.331" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="32.011" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g904622g0110045741416.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g904622g0110045741416.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !$ 'T# 2(  A$! Q$!_\0
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MU;^TXX_*2Z,B>4JEP2LBMR1QGCFNPHHH 2BBB@ HHHH **** "BBB@ HHHH
.**** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm46007648209120">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Jan. 09, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jan.  09,  2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Repare Therapeutics Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">A8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-39335<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">00-0000000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address Address Line 1</a></td>
<td class="text">7171 Frederick-Banting, Building 2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address Address Line 2</a></td>
<td class="text">Suite 270<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address City Or Town</a></td>
<td class="text">St-Laurent<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address State Or Province</a></td>
<td class="text">QC<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address Country</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address Postal Zip Code</a></td>
<td class="text">H4S&#160;1Z9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">857<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">412-7018<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common shares, no par value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">RPTX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001808158<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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M1S &P %#TG1X#SY['R73>RHY_U=3_ 102P,$%     @ ,S@J6I>*NQS
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M=1,92L88!.R '<(Y_<Z[5ITPX1X=\G>A^[<#K3P&]'@!6^A<JU3'\TLDO,3
MQFU+BLX5>C(,=D",Y1]XVXG\-/O4(VSV'T:$%'J6"V&%E+C?Z/F-:#R!+ ]=
MR_$)'0.M#,,SQ;;!<.AHQ$5V9://8:Q#B'/Z3XRQJK"$52Q;#X&'' E<)S"D
M&IND53 >"CVN*!.L>@PL(:EU&*ADMW,JI]=V<,TB]RI#FJ,,:&T'X:-:"Q4&
ML&]R( DNR94;4EWI>::W=Y-[2:AU[D&P]_ :C1W-CQ^W_ %02P,$%     @
M,S@J6B0>FZ*M    ^ $  !H   !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L
M<[61/0Z#, R%KQ+E #50J4,%3%U8*RX0!?,C$A+%K@JW+X4!D#IT8;*>+7_O
MR4Z?:!1W;J"V\R1&:P;*9,OL[P"D6[2*+L[C,$]J%ZSB688&O-*]:A"2*+I!
MV#-DGNZ9HIP\_D-T==UI?#C]LCCP#S"\7>BI160I2A4:Y$S":+8VP5+BRTR6
MHJ@R&8HJEG!:(.+)(&UI5GVP3TZTYWD7-_=%KLWC":[?#'!X=/X!4$L#!!0
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M&G_FB^$_7G\!4$L! A0#%     @ ,S@J6@=!36*!    L0   !
M     ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    "  S."I:)U2[
MX^T    K @  $0              @ &O    9&]C4')O<',O8V]R92YX;6Q0
M2P$"% ,4    "  S."I:F5R<(Q &  "<)P  $P              @ '+ 0
M>&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( #,X*EI%,.$H<00  ,41
M   8              " @0P(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q0
M2P$"% ,4    "  S."I:GZ ;\+$"  #B#   #0              @ &S#
M>&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( #,X*EJ7BKL<P    !,"   +
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4!08     "0 ) #X"   3%      !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d904622d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000001 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.reparerx.com//20250109/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" original="d904622d8k.htm">d904622d8k.htm</File>
    <File>rptx-20250109.xsd</File>
    <File>rptx-20250109_lab.xml</File>
    <File>rptx-20250109_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="24">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "d904622d8k.htm": {
   "nsprefix": "rptx",
   "nsuri": "http://www.reparerx.com/20250109",
   "dts": {
    "inline": {
     "local": [
      "d904622d8k.htm"
     ]
    },
    "schema": {
     "local": [
      "rptx-20250109.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "rptx-20250109_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "rptx-20250109_pre.xml"
     ]
    }
   },
   "keyStandard": 24,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2024": 3
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 25,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 24
   },
   "report": {
    "R1": {
     "role": "http://www.reparerx.com//20250109/taxonomy/role/DocumentDocumentAndEntityInformation",
     "longName": "000001 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "duration_2025-01-09_to_2025-01-09",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d904622d8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "duration_2025-01-09_to_2025-01-09",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d904622d8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.reparerx.com//20250109/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.reparerx.com//20250109/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "terseLabel": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.reparerx.com//20250109/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://www.reparerx.com//20250109/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "terseLabel": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.reparerx.com//20250109/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address Address Line 1",
        "terseLabel": "Entity Address Address Line 1",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://www.reparerx.com//20250109/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address Address Line 2",
        "terseLabel": "Entity Address Address Line 2",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.reparerx.com//20250109/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address City Or Town",
        "terseLabel": "Entity Address City Or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://www.reparerx.com//20250109/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address Country",
        "terseLabel": "Entity Address Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.reparerx.com//20250109/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address Postal Zip Code",
        "terseLabel": "Entity Address Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.reparerx.com//20250109/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address State Or Province",
        "terseLabel": "Entity Address State Or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.reparerx.com//20250109/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.reparerx.com//20250109/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.reparerx.com//20250109/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "terseLabel": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.reparerx.com//20250109/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.reparerx.com//20250109/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.reparerx.com//20250109/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.reparerx.com//20250109/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.reparerx.com//20250109/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.reparerx.com//20250109/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.reparerx.com//20250109/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.reparerx.com//20250109/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.reparerx.com//20250109/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.reparerx.com//20250109/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.reparerx.com//20250109/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "terseLabel": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001193125-25-004065-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-25-004065-xbrl.zip
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M$%RC! \4':#7!&4D?1RR AX12WT9>V"S7KG>CDH79(@W 4M*V[2M4YF+QZ,
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MA .!L#9!HX$0^":R0M)<HUN97X[F7V[?>:H*Z2!<4A.)QGYLA%*Y8WQ.U^2
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M&W%)]L4D3H0?))OY(O46<5&<3$V<=31!O<V"U+P+$6QH^2(H=.3A'O_YC%[
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MD](UZ^S^^LLG;N21^DM!^2F:_;T<>>9_4$L#!!0    ( #,X*EK2YG,:L 0
M -DM   5    <G!T>"TR,#(U,#$P.5]P<F4N>&ULU9I1;^HV&(;OCW3^@Y?=
M;-)""-!UH-(C1-L)C;:H<+9I-Y-)/L":8T>V*?#O9P?<)A!ZH&=GBKD@P?'[
M^?7W.(EQ<O5IG5#T#$(2SKI>6*M["%C$8\+F76\I?2PC0CPD%68QIIQ!U]N
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MAKK O*>\/6*^S%NWNN1?4$L! A0#%     @ ,S@J6LNM\!77%@  08$   X
M             ( !     &0Y,#0V,C)D.&LN:'1M4$L! A0#%     @ ,S@J
M6O!-!297%   &TT  !$              ( ! Q<  &0Y,#0V,C)D97@Y.3$N
M:'1M4$L! A0#%     @ ,S@J6GL[2VKR @  \@D  !$              ( !
MB2L  ')P='@M,C R-3 Q,#DN>'-D4$L! A0#%     @ ,S@J6OY"'W-^!@
M6TD  !4              ( !JBX  ')P='@M,C R-3 Q,#E?;&%B+GAM;%!+
M 0(4 Q0    ( #,X*EK2YG,:L 0  -DM   5              "  5LU  !R
J<'1X+3(P,C4P,3 Y7W!R92YX;6Q02P4&      4 !0!  0  /CH

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>d904622d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="rptx-20250109.xsd" xlink:type="simple"/>
    <context id="duration_2025-01-09_to_2025-01-09">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808158</identifier>
        </entity>
        <period>
            <startDate>2025-01-09</startDate>
            <endDate>2025-01-09</endDate>
        </period>
    </context>
    <dei:EntityTaxIdentificationNumber
      contextRef="duration_2025-01-09_to_2025-01-09"
      id="Hidden_dei_EntityTaxIdentificationNumber">00-0000000</dei:EntityTaxIdentificationNumber>
    <dei:AmendmentFlag
      contextRef="duration_2025-01-09_to_2025-01-09"
      id="Hidden_dei_AmendmentFlag_duration_2025-01-09_to_2025-01-09">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2025-01-09_to_2025-01-09"
      id="Hidden_dei_EntityCentralIndexKey_duration_2025-01-09_to_2025-01-09">0001808158</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2025-01-09_to_2025-01-09" id="Fact_1">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2025-01-09_to_2025-01-09" id="Fact_0">2025-01-09</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="duration_2025-01-09_to_2025-01-09" id="ixv-282">Repare Therapeutics Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2025-01-09_to_2025-01-09" id="ixv-283">A8</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2025-01-09_to_2025-01-09" id="ixv-284">001-39335</dei:EntityFileNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2025-01-09_to_2025-01-09" id="ixv-285">7171 Frederick-Banting, Building 2</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="duration_2025-01-09_to_2025-01-09" id="ixv-286">Suite 270</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="duration_2025-01-09_to_2025-01-09" id="ixv-287">St-Laurent</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2025-01-09_to_2025-01-09" id="ixv-288">QC</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressCountry contextRef="duration_2025-01-09_to_2025-01-09" id="ixv-289">CA</dei:EntityAddressCountry>
    <dei:EntityAddressPostalZipCode contextRef="duration_2025-01-09_to_2025-01-09" id="ixv-290">H4S&#160;1Z9</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2025-01-09_to_2025-01-09" id="Fact_3">857</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2025-01-09_to_2025-01-09" id="Fact_4">412-7018</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2025-01-09_to_2025-01-09" id="ixv-293">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2025-01-09_to_2025-01-09" id="ixv-294">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2025-01-09_to_2025-01-09" id="ixv-295">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2025-01-09_to_2025-01-09" id="ixv-296">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2025-01-09_to_2025-01-09" id="ixv-297">Common shares, no par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2025-01-09_to_2025-01-09" id="ixv-298">RPTX</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2025-01-09_to_2025-01-09" id="ixv-299">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2025-01-09_to_2025-01-09" id="ixv-300">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
